{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:06:10Z","timestamp":1791198370736,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ymgme.2012.02.006","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T20:18:26Z","timestamp":1328905106000},"page":"131-134","source":"Crossref","is-referenced-by-count":55,"title":["Lysosomal enzyme can bypass the blood\u2013brain barrier and reach the CNS following intranasal administration"],"prefix":"10.1016","volume":"106","author":[{"given":"Daniel A.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena L.","family":"Aronovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"McIvor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.02.006_bb0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/mp900275s","article-title":"Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy","volume":"7","author":"Shingaki","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2010.1130","article-title":"Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease","volume":"14","author":"Danielyan","year":"2011","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0020","first-page":"418","article-title":"Gene delivery into the central nervous system by nasal instillation in rats","volume":"2","author":"Draghia","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0025","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ymthe.2003.09.010","article-title":"Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis","volume":"8","author":"Jerusalmi","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0035","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ymthe.2005.12.013","article-title":"Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice","volume":"13","author":"Laing","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0040","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0045","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system","volume":"98","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0050","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/jps.21674","article-title":"Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake","volume":"98","author":"Vaka","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/JAD-2009-0953","article-title":"Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice","volume":"16","author":"Capsoni","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2003.12.005","article-title":"Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze","volume":"361","author":"Alcalay","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations J","volume":"99","author":"Dhuria","year":"2010","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0070","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/10717544.2011.557785","article-title":"Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia","volume":"18","author":"Zhu","year":"2011","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0075","first-page":"257","article-title":"Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction","volume":"19","author":"Zhao","year":"2004","journal-title":"Chin. Med. Sci. J."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0080","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2011.02.015","article-title":"Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I","volume":"43","author":"Wolf","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brainresbull.2007.07.018","article-title":"Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy","volume":"74","author":"Garcia-Rivera","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0095","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/mt.2009.87","article-title":"Systemic correction of storage disease in MPS I NOD\/SCID mice using the sleeping beauty transposon system","volume":"17","author":"Aronovich","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2008.10.009","article-title":"A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I","volume":"96","author":"Giugliani","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0105","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0110","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem. Mol. Med."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2011.03.011","article-title":"Biodistribution and pharmacodynamics of recombinant human alpha-l-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations Mol","volume":"103","author":"Vite","year":"2011","journal-title":"Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.02.006_bb0125","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","article-title":"Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression","volume":"146A","author":"Munoz-Rojas","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2012.02.006_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T14:32:04Z","timestamp":1561300324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1096719212000315"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.02.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}